ClinicalTrials.Veeva

Menu

Prophylactic Analgesic and Antiemetic Regimen for Medical Abortion < 70 Days

Hackensack Meridian Health logo

Hackensack Meridian Health

Status and phase

Terminated
Early Phase 1

Conditions

Nausea
Pain

Treatments

Drug: Use of ibuprofen and ondansetron at symptom onset post misoprostol administration
Drug: Prophylactic use of ibuprofen and ondansetron post misoprostol administration

Study type

Interventional

Funder types

Other

Identifiers

NCT05819619
Pro2021-1405

Details and patient eligibility

About

Randomized trial which will aim to evaluate whether prophylactic use of ondansetron and ibuprofen will decrease side effects associated with medical abortion and increase patient satisfaction.

Enrollment

8 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Healthy
  • English speaking
  • female volunteers undergoing medical abortion whether for voluntary interruption of pregnancy or missed abortion
  • Gestational age </= 70 days confirmed via ultrasound
  • Access to a time keeping device
  • Willingness to complete a telephone or in-clinic follow up

Exclusion criteria

  • chronic medical problems including but not limited to cardiac conditions, malignancy or organ damage
  • Failed medical abortion resulting in surgical management
  • Known intrauterine infection
  • Known allergy to ondansetron or ibuprofen
  • Subjects chronically receiving analgesic drugs
  • Subjects unable to give consent
  • Subjects taking medications that interact with ondansetron or ibuprofen

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

8 participants in 2 patient groups

Standard of care
Active Comparator group
Description:
Administration of ibuprofen or ondansetron only when experiencing pain or nausea respectively post misoprostol administration.
Treatment:
Drug: Use of ibuprofen and ondansetron at symptom onset post misoprostol administration
Prophylactic use
Experimental group
Description:
Administration of ibuprofen and ondansetron at the time of misoprostol administration.
Treatment:
Drug: Prophylactic use of ibuprofen and ondansetron post misoprostol administration

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Antonia Oladipo, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems